MENU
Advertisement
Table of Contents
Supplement
September 2017 Supplement
Evidence From the Next-Generation DCB
Delivering top-tier clinical outcomes.
Sponsored by Spectranetics Corporation
Issue
SFA
The Forces Driving Care
View Issue
Comparative Analysis of Drug-Coated Balloons
By Juan F. Granada, MD, FACC
The Stellarex Difference: Critical Components of an Optimal DCB
By Manasi Ramachandran, PhD, and Michael S. Owens, PhD
The ILLUMENATE SFA Clinical Program
Data on the Stellarex DCB for treatment of femoropopliteal arterial disease.
By Henrik Schröder, MD; and Prakash Krishnan, MD
Vessel Preparation With Laser Atherectomy and Scoring Balloon Angioplasty Before Drug-Coated Balloon Angioplasty
By Ehrin J. Armstrong, MD
The What, Why, and How of Shockwave’s Peripheral Balloon IVL Platform
With Samuel Leonard, MD, and Mathew Wooster, MD, MBA
Navigating the 2026 Lower Extremity CPT Code Restructure
By Jeffrey G. Carr, MD
A Private Practice Physician’s Experience Treating Chronic Venous Insufficiency
By Robert A. Edwards, DO
The Next Generation in Carotid Stenting
With Edvard Skripochnik, MD; Anish J. Thomas, MD, FACC, FSCAI; and Mehdi Bouslama, MD, MSc
Training the Next Generation of Aortic Specialists
By Eric J. Finnesgard, MD, MS, and Andres Schanzer, MD
Latest Issues
June 2026
May 2026
April 2026
March 2026
February 2026
View All Issues